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Strengths and limitations of this study
 ► Largest study of depressive symptoms and general 
health in ex-professional footballers and controls in 
the UK.
 ► Case-control study design with control male partici-
pants recruited from a community-based population 
sample representative of the UK general population.
 ► Outcomes were self-reported by participants using 
postal questionnaires.
 ► Lack of current or previous physical activity levels 
assessed.
 ► Higher response rate in the ex-footballers compared 
with the control participants.
AbStrACt
Objectives To determine the prevalence of depressive 
symptoms and general health of male ex-professional 
footballers compared with general population controls.
Methods 572 retired professional footballers and 500 
general population controls in the UK were assessed by 
postal questionnaire. Anxiety and depressive symptoms were 
assessed using the Hospital Anxiety and Depression Scale 
and a threshold score of ≥11 was used to indicate probable 
caseness. General health was ascertained using the Short 
Form-12 Health Survey Questionnaire quality of life (QoL) 
tool; self-reported comorbidities, analgesic usage and body 
pain; and Index of Multiple Deprivation based on postcode 
data. Mood was assessed using the Positive and Negative 
Affect Scale and sleep using the Medical Outcome Survey. 
Linear regression analysis was used to determine adjusted 
relative risk with 95% CI and adjusted for age, body mass 
index, comorbidities, body pain and medication usage.
results The prevalence of depressive symptoms in 
retired professional footballers was 5.66% compared with 
5.76% in the general population and anxiety prevalence 
was also comparable (12.01% vs 10.29%; all p>0.05). 
However, footballers had lower physical and mental 
component scores compared with controls (p<0.01). 
They also reported significantly more sleep problems, 
more negative mood profiles and more widespread body 
pain (adjusted relative risk (aRR) 1.88, 95% CI 1.15 to 
3.09). They also reported greater pain medication usage 
compared with controls (aRR 1.54, 95% CI 1.26 to 1.89). 
However, compared with controls, they were 26% (95% CI 
15% to 37%) less likely to report comorbidities, especially 
heart attacks (aRR 57%, 95% CI 27% to 74%) and 
diabetes (aRR 61%, 95% CI 37% to 76%).
Conclusions The prevalence of depressive symptoms 
and anxiety symptoms and probable caseness in ex-
professional footballers is comparable with general 
population controls. However, ex-footballers reported lower 
health-related QoL, more widespread body pain and higher 
analgesic usage. Conversely, lower reporting of diabetes 
and heart attacks indicates potential long-term physical 
health benefits of professional football.
IntrOduCtIOn
Football is the world’s most popular sport with 
over 300 million active players worldwide and 
110 000 athletes registered at a professional 
level.1 There has been considerable interest 
in whether the mental health of athletes is 
often compromised, especially by anxiety and 
depression.2 Retired professional footballers 
may experience unique psychological stress 
factors primarily due to the nature and the 
intensity of the sport, where severe or recur-
rent injuries are common.3 Also, the pressures 
of competition, training and maintaining 
high-performance levels are hallmarks of a 
successful professional career.4 The intensity 
of mental and physical demands may increase 
their susceptibility to certain mental health 
problems and risk-taking behaviour.
Despite individual high-profile cases of 
depression in professional footballers in the 
UK (eg, Gary Speed, Paul Gascoigne and 
Clarke Carlisle), there is a lack of robust 
epidemiological studies on mental health 
issues in professional footballers. Studies on 
European former professional footballers 
from countries such as the Netherlands have 
reported anxiety and depression prevalence 
figures ranging from 25% to 43%.5 However, 
none of these studies included a non-athlete 
or general population comparison group. A 
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recent systematic review suggests that despite a seemingly 
higher risk of anxiety and depression in athletes in a range 
of elite sports, the figures are broadly comparable with 
the general population. The review further concluded 
that the evidence base is restricted by a paucity of high-
quality study designs, particularly in professional footbal-
lers.6 Turner et al7 also found that anxiety and depression 
featured in 37% of former players with knee pain and 
knee osteoarthritis. A subsequent phenomenological 
study8 suggested that these may be common sequelae of 
significant sport injuries that caused frustration and asso-
ciated participation restrictions and limitations to work, 
social and leisure activities. However, studies focused on 
mental health and quality of life (QoL) of athletes are 
limited by study design, lack of power and small sample 
sizes, and comparison across sporting populations.2 9–12 
Therefore, there is a need for studies that are focused on 
an individual sport, such as professional football and its 
full-time players; are adequately powered for depression 
outcomes; include an age-adjusted control population; 
and investigate comorbidities and auxiliary measures of 
mental health and QoL indicators, such as sleep patterns, 
mood profiles and pain distribution, including use of 
pain medication.
Therefore, based on previous research and the gaps 
in the evidence base, the objectives of the present study 
were (1) to determine the prevalence of anxiety and 
depressive symptoms and probable caseness for each in 
retired professional footballers compared with general 
population controls; (2) to determine the general health 
in retired professional footballers compared with general 
population controls; and (3) to determine the risk and 
protective factors associated with professional football.
MethOdS
A cross-sectional design was used, involving a series of 
postal questionnaire surveys to ex-footballers and to a 
sample of men in the general population (aged 40 years 
and over) to gain information on symptoms of anxiety 
and depression, mood and sleep, as well as well as simple 
demographics, occupational history, general health 
(comorbidities) and current medications. The exclusion 
criteria at baseline were known terminal illness, severe 
psychiatric illness or dementia, or any other condition 
or circumstance considered by their general practice to 
make them unsuitable to receive the questionnaire.
Patient and public involvement
The study was supported by a patient advisory group that 
provided input to the programme of research. Patients 
and ex-professional footballers partnered with us for the 
design of the study, the informational material to support 
the intervention and the burden of the questionnaire 
from the patient’s perspective. At the end of the study, the 
patient advisory group commented on the findings and 
contributed to the dissemination plan, and this included 
input on poster and oral presentations at local, national 
and international conferences.
Participants
The recruitment of the source sample of ex-footballers 
and general population controls has been detailed in 
a previous publication examining the risk of knee pain 
and osteoarthritis in the footballers versus the controls.13 
Ex-footballers were recruited via the Professional Footbal-
lers’ Association and former players’ associations (N=21 
professional clubs). Inclusion criteria for ex-footballers 
were men aged over 40 years who had played profes-
sionally (in the top four tiers of the English Football 
League). The comparison group was recruited from the 
Knee Pain and Related Health in the Community Study, 
involving recruitment via 12 general practitioner (GP)/
family medicine practices in the UK Midlands region. 
All men on these UK National Health Service GP regis-
ters aged 40 years and older who were not terminally ill 
were able to give written informed consent and had no 
other reason judged by the GPs to exclude them from 
the study were sent the questionnaire. Individuals who 
indicated interest in further research conducted by the 
University of Nottingham were subsequently contacted 
with a follow-up questionnaire focused on mental health 
and QoL.
Questionnaire survey
The postal questionnaire was developed based on previ-
ously published questionnaires and using extensively 
validated tools in the retired footballers and the control 
population. Through public and patient involvement, 
pilot versions of the questionnaire were evaluated to 
identify any problems with content, language and layout. 
The questionnaires were similarly constructed to capture 
detailed information about all participants (including 
football career history for retired footballers), anthropo-
metric details (age and body mass index (BMI)), medical 
history and current medication usage.
Age and bMI
Participants self-reported their date of birth and height 
and weight in the returned questionnaires. BMI was 
calculated as the weight divided by the square of height 
(kg/m2).
Symptoms of anxiety and depression
Anxiety and depressive symptoms were determined using 
the Hospital Anxiety and Depression Scale (HADS), 
which is composed of 14 items, equally divided between 
the two mood states (anxiety and depression). Each item 
has a 4-point rating scale. Responders are asked to indicate 
their feelings based on the previous 1 week, with recom-
mended cut-off points indicating whether the responder 
is (1) within the normal range (scores of 0–7), (2) 
mild–moderate caseness (scores of 8–10) and (3) severe 
caseness (scores of 11–21). Although cut-offs of >8 have 
been used in some studies to indicate anxiety or depres-
sion,14 this threshold is considered too low and lacking 
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in sensitivity for use in a general population sample,15 so 
a cut-off of ≥11 was used to identify definite anxiety and 
definite depression. This cut-off has been defined using 
psychiatric ratings of anxiety and depression disorders.16 
While the gold standard for a clinical diagnosis of gener-
alised anxiety disorder or major depressive disorder is a 
detailed evaluation of symptom criteria using the Diag-
nostic and Statistical Manual of Mental Disorders (DSM-5), 
research has shown that it compares consistently with 
HADS data both for sensitivity and specificity.17 As the 
HADS is also simple, easy to administer and relatively 
short compared with the DSM-5,18 we chose to include it 
as part of the postal questionnaires mailed to over 40 000 
participants in this study.
QoL measures, MCS and PCS
QoL was assessed using the Medical Outcome Study 
Short Form-36 Health Survey Questionnaire (SF-36) 
in the ex-footballers, which was converted into SF-12, 
and the Medical Outcome Study Short Form-12 Health 
Survey Questionnaire (SF-12) in the general population 
controls. The difference in SF versions used was due 
to logistical factors: the SF-12 was a survey embedded 
within a questionnaire posted to the general population 
controls whose focus was on knee osteoarthritis outcomes 
and not mental health per se. As a result of these page 
restrictions, we used the shortened version, SF-12, for the 
controls compared with the second follow-up question-
naire posted to the ex-footballers, which contained the 
SF-36. In order to aid comparison, the SF-36 outcomes 
were transformed into SF-12 outcomes as detailed by 
Jenkinson and colleagues.19 Each SF response was used 
to calculate scores in each of the eight domains: physical 
functioning, role physical, bodily pain, general health 
perception, vitality, social functioning, role emotional 
and mental health. These figures were then standardised 
using z-score transformations using means and SDs 
previously described.19 Using the z-scores for each scale, 
the aggregate score for two summary scales, the Mental 
Health Component Score (MCS) and the Physical Health 
Component Score (PCS), were calculated. Finally, the 
scores were standardised to a T-score, where the mean was 
set to 50 and the SD was set to 10. For the SF-12, scoring 
was conducted according to previously published data.20 21 
Item weights for response categories from an American 
population-based study, which was found comparable 
with other population studies in nine other countries, 
including the UK, was used to standardise responses.19 
There is considerable evidence suggesting that the PCS 
and MCS from the SF-12 show similar levels of precision 
to the summary scores derived from the longer SF-36 
version. Even though summary scores are not exactly 
identical, the level of difference between the two is small 
and is not subjectively or clinically meaningful.22
Medical Outcome Survey (MOS) Sleep Scale
The sleep scale from MOS is a 12-item measure that 
is generic and not disease specific, and measures six 
dimensions of sleep: sleep disturbance, snoring, shortness 
of breath with headache, sleep adequacy, somnolence 
and quantity of sleep.23 The tool has demonstrated excel-
lent reliability and validity for assessing sleep in commu-
nity samples.24 25 A sleep problems index (SLP-9) can be 
calculated using nine items from the MOS Sleep Scale 
indicating quality of sleep on a 0–100 scale. The higher 
the score, the lower the quality of sleep. The quantity of 
sleep is recorded as the average hours of sleep per night 
over the previous 4-week period and was dichotomised as 
optimal sleep (if this was 7–8 hours) or non-optimal (if 
this was less than 7 hours or greater than 8 hours) as per 
MOS sleep scoring criteria.
Positive and negative Affect Scale (PAnAS)
PANAS is a self-report questionnaire comprising two 
10-item scales, which describe different feelings and 
emotions measuring both positive and negative affects.26 
The questionnaire asked responders to consider their 
feelings at the time of completing the questionnaire. The 
normal population reference guide for the mean positive 
affect score was 29.7 (+7.9) and that for the mean nega-
tive affect score was 14.8 (+5.4). PANAS has demonstrated 
high reliability and construct validity, is brief and ideal 
for use in self-reported questionnaires and has been used 
extensively alongside measures of anxiety and depression 
such as HADS.27 28
Indices of Multiple deprivation
The Index of Multiple Deprivation is an official measure of 
the relative deprivation in England.29 It ranks all areas in 
England from 1 (most deprived) to 32 844 (least deprived 
area) and is based on weights given to key domains such 
as income, employment, education and housing. It uses 
postcodes to determine an overall measure of depriva-
tion. This information was then presented in quintiles 
with percentage of footballers and controls within the 
lowest and highest quintiles.
Comorbidities
Individual comorbidities were self-reported according to 
a brief specific checklist enquiry (fibromyalgia, diabetes, 
heart attacks, hypertension and cancer), with data dichot-
omised into individuals with or without these conditions. 
An open-text question was also included to capture infor-
mation on any other diagnosed medical conditions not 
on the checklist.30
Widespread body pain
Widespread body pain was self-reported using a body pain 
mannequin.31 It was scored using the American College 
of Rheumatology criteria for widespread body pain, 
whose definition is pain in each of the four quadrants of 
the body including the spinal or axial column. Reported 
pain in any part of the body was dichotomous (present/
absent) and the total number of regions with pain was a 
simple count of the shaded regions of the manikin.
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Figure 1 Selection of ex-footballer and general population 
controls.
Table 1 Characteristics of footballer and control populations
Footballers, n=572 Controls, n=500 P value
Age (years), mean (SD) 60.11 (10.77) 64.26 (9.37) <0.001
BMI (kg/m2), mean (SD) 27.13 (3.40) 27.29 (4.48) 0.51
HADS Anxiety Score >11, n (%) 70 (12.01) 50 (10.29) 0.34
HADS Depression Score >11, n (%) 33 (5.66) 28 (5.76) 0.94
SF Physical Component Score, mean (SD) 45.33 (10.32) 77.60 (8.35) <0.001
SF Mental Component Score, mean (SD) 48.09 (7.47) 71.87 (6.64) <0.001
Optimal sleep (7–8 hours per night), n (%) 369 (64.51) 275 (56.70) 0.01
Sleep Problem Index (SIP) in highest tertile, n (%) 186 (33.04) 131 (26.90) 0.03
Positive mood, mean (SD) 34.75 (8.05) 34.97 (6.86) 0.63
Negative mood, mean (SD) 16.5 (6.72) 14.22 (4.95) <0.001
Indices of Multiple Deprivation in the lowest and highest quintile, n (%) 17 (3.51) 84 (17.28) <0.001
205 (42.27) 199 (40.95) 0.18
BMI, body mass index; HADS, Hospital Anxiety and Depression Scale; SF, Short Form.
Pain-relieving medication
Self-reported analgesic medication (both prescribed 
and over the counter) was recorded and grouped as all 
pain-relieving medication, and subgrouped as non-ste-
roidal anti-inflammatory drugs (NSAIDs), opioids, other 
over-the-counter (OTC) and prescribed analgesics, and 
other medications with pain-modifying properties (eg, 
citalopram and amitriptyline).
Statistical analyses
A power calculation was conducted based on a 12.6% 
prevalence of depressive symptoms in a non-clinical 
sample of community-derived adults using the HADS15 
and an OR of 2 after adjustment for other known factors 
in ex-footballers. The sample size required to detect this 
OR, with 90% power and a 0.05% significance level, was 
336 participants per group.
Categorical variables were reported as frequencies and 
percentages, and continuous variables were reported as 
means and SDs. To determine whether distributions of 
the variables were statistically significant between ex-foot-
ballers and controls, a t-test (continuous variables) or 
a χ2 test (categorical variables) was used. For the SF-12 
outcomes, specifically the PCS and MCS between foot-
ballers and controls, we used the rank-sum command in 
Stata, which compared two independent samples using 
the Mann-Whitney two-sample statistic. Statistical signif-
icance was defined as p<0.05. We had very few missing 
data at random (eg, where BMI was not reported by a 
participant). Imputation or modelling was therefore not 
undertaken for the occasional missing values. Details on 
missing data have previously been published.13
All analyses were conducted using Stata IC V.14 on 
Windows 7 Operating System, and power calculations 
were undertaken using OpenEpi V.3.
reSuLtS
Of the 898 questionnaires sent to the retired professional 
footballers, 572 responses were received (63.7% response). 
Of 2215 questionnaires sent to general population controls, 
500 questionnaires were received (22.6% response) 
(figure 1).
The mean age of the ex-footballers was significantly 
younger than that of the controls (60 vs 64 years), but the 
mean BMIs were comparable (table 1).
The prevalence of probable depression was similar in the 
footballers and controls (5.7% vs 5.8%), but the prevalence 
of probable anxiety was slightly higher in the footballers 
(12.0% vs 10.3%), though this was not statistically signifi-
cant. Although footballers and controls shared a similar 
positive mood profile, footballers were significantly more 
likely to experience negative moods compared with the 
controls and to have greater problems with sleep quality 
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Table 2 Comparison of self-reported comorbidities, pain and medication in the ex-footballers compared with the general 
population controls
Footballers,
n=572
Controls,
n=500 P value
Adjusted relative risk (95% 
CI) (for age and BMI)
Comorbidities*
n (%)
178 (30.58) 260 (52.31) <0.001 0.74 (0.63 to 0.85)†
Comorbidities (by Charlson Comorbidity 
Index weighting, mean (SD)), n(%)‡
0.44 (0.80) 0.75 (0.98) <0.001 0.71 (0.6–0.85)†
Diabetes, n (%) 22 (3.77) 57 (11.47) <0.001 0.39 (0.24 to 0.63)†
Cancer, n (%) 40 (6.86) 50 (8.58) 0.07 0.88 (0.59 to 1.30)
Heart attacks, n (%) 18 (3.08) 47 (9.46) <0.001 0.43 (0.26 to 0.73)†
Hypertension, n (%) 134 (22.98) 169 (34.00) <0.001 0.79 (0.65 to 0.96)†
Fibromyalgia, n (%) 3 (0.51) 1 (0.20) 0.39 3.08 (0.31 to 31.02)
Any body pain, n (%) 454 (78.14) 330 (71.90) 0.02 1.09 (1.00 to 1.17)§
ACR criteria widespread body pain (no knee 
pain), n (%)
48 (8.40) 23 (4.60) 0.01 1.88 (1.15 to 3.09)§
Total regions with pain, mean (SD) 3.13 (3.29) 3.44 (3.05) 0.14 0.91 (0.79 to 1.05)
Back pain, n (%) 176 (30.18) 146 (29.38) 0.57 1.00 (0.76 to 1.32)
Knee pain, n (%) 337 (57.80) 193 (38.83) <0.001 1.47 (1.29 to 1.69)§
Pain medication use, n (%) 240 (41.17) 165 (33.20) 0.007 1.54 (1.26 to 1.89)§
Opioids, n (%) 23 (4.03) 32 (6.40) 0.07 0.64 (0.37 to 1.10)
NSAIDS, n (%) 49 (8.58) 21 (4.20) 0.004 1.94 (1.19 to 3.20)§
OTC analgesics, n (%) 137 (23.99) 70 (14.00) <0.001 1.86 (1.44 to 2.43)§
Other medications, n (%)¶ 18 (3.15) 31 (6.20) 0.01 0.50 (0.28–0.94)†
*Diabetes, hypertension, myocardial infarction, cancer and fibromyalgia.
†Protective factors.
‡Includes myocardial infarction, hypertension, diabetes and cancer.
§Risk factors.
¶Other medications with pain-relieving effects.
ACR, American College of Rheumatology; NSAID, non-steroidal anti-inflammatory drug; OTC, over-the-counter.
(p<0.05). When using the sleep problem Sleep Problem 
Index, more footballers reported problems with sleep 
quality (p<0.05) and poor sleep patterns, which included 
restlessness, shortness of breath and drowsiness. They were 
also more likely to have lower scores in terms of both their 
PCS and MCS, as indicated by the SF-12 QoL measure.
With respect to social deprivation, fewer footballers 
(3.51%) were living in areas marked as the most deprived 
compared with the control population (17.28%, p<0.001).
Risk factors associated with professional football 
following adjustment for age and BMI are presented in 
table 2. Ex-footballers overall were less likely to present 
with any comorbidity (diabetes, hypertension, myocardial 
infarction, cancer and fibromyalgia), especially diabetes 
(adjusted relative risk (aRR) 61%, 95% CI, 37% to 76%), 
heart attacks (aRR 57%, 95% CI 27% to 74%) and hyper-
tension (aRR 21%, 95% CI 4% to 35%). However, foot-
ballers reported more widespread body pain using the 
American College of Rheumatology (ACR) criteria (aRR 
88%, 95% CI 15% to 30.9%). Footballers also consumed 
more NSAIDs (8.6% vs 4.2%) and OTC analgesics (24% 
vs 14%) but not opioids (4% vs 6.4%) compared with the 
controls.
dISCuSSIOn
This is the first study to report the prevalence of symp-
toms of depression and anxiety and the general health 
and QoL of retired professional footballers compared 
with a control population. The main findings are (1) the 
prevalence of probable depression and anxiety in the 
ex-footballers is comparable to men in the general popu-
lation; (2) ex-footballers have a lower QoL as indicated 
by the SF-12 PCS and MCS; (3) they are more likely to 
present with widespread body pain and use pain medi-
cation particularly OTC analgesics and NSAIDs; and (4) 
they are less likely to present with comorbidities, in partic-
ular diabetes, heart attacks and hypertension.
The study reported a prevalence of probable depres-
sion (6%) and anxiety (12%) in ex-footballers, which is 
lower than the 25%–43% as reported by Gouttebarge et 
al.5 This discrepancy could result from smaller sample 
sizes (range of 70–149 ex-players), sample selection and 
status of footballers (current professional footballers from 
five different European countries) and the assessment 
tool used to determine depression and anxiety (12-item 
general health questionnaire (GHQ-12)) in that study. In 
a further study32 specifically investigating ex-footballers, a 
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39% prevalence of both anxiety and depression using the 
GHQ-12 was estimated. A number of self-report assess-
ment tools have been used in epidemiological research to 
detect depression and anxiety.32–34 While the GHQ-12 has 
demonstrated excellent validity in detecting depression 
in the general population,35 the HADS has demonstrated 
better sensitivity and specificity in detecting depression. 
Indeed, the choice of assessment tool should be balanced 
with feasibility of approach, cost effectiveness, as well as 
the administration and scoring times involved.32 Addi-
tionally, none of the previous studies in ex-footballers 
presented results for an adequately matched comparison 
group of non-professional footballers. The results of this 
study accord with a comparative meta-analysis in high-per-
formance athletes and non-athletes showing similar levels 
of depression across the groups.4 Elite athletes are some-
times supported with psychological training as part of 
their sport programme and may have developed mental 
toughness and resilience in order to cope with stress, 
anxiety and even depression.36–39 There is a noted stigma 
about reporting mental health symptoms in both ex-foot-
baller and general population samples, which may result 
in choosing to suppress, ignore and not seek further 
help when needed.6 35 40 Furthermore, when compared 
with another general population study, the prevalence of 
depression (7%–9%) and anxiety (8%–14%) in general 
population men aged 40–65 years is comparable to the 
controls in this study, suggesting that this East Midlands 
control population is representative of the British general 
population and is a valid control group.41
In terms of QoL, the ex-footballers had significantly 
lower scores in both physical and mental components 
compared with controls. It has been postulated that this 
negative effect on QoL is a consequence of reporting 
more specific joint pain (eg, knee pain) and more overall 
body pain.13 42 Although both the ex-footballers and 
the control population indicated pain in one region on 
a body pain manikin (78% vs 72%), after adjustment 
for age and BMI, ex-footballers are 88% more likely to 
present with widespread body pain when using the more 
stringent ACR criteria compared with the control group. 
Widespread pain can have significant, deleterious effects 
on physical and mental health and well-being,43 including 
implications on sleep disturbance and mood. Longitu-
dinal cohort studies have shown that insomnia and sleep 
disturbances significantly increase the risk of chronic 
pain in pain-free individuals at baseline, while pain is 
not a strong predictor of insomnia.44 As a result of the 
cross-sectional nature of this study, we cannot ascertain 
causation between pain and sleep. However, the results 
in ex-footballers show that while sleep duration may be 
marginally better (64.5 vs 56.7% for 7–8 hours of sleep), 
the quality of sleep was more disturbed in terms of restless-
ness, feeling tense or drowsy compared with controls. The 
effect on mood is also notable with ex-footballers more 
likely to present with negative feelings and emotions such 
as distress, irritability, fear and nervousness compared 
with controls. The association of emotional distress and 
pain-related fear on patients with chronic pain has been 
established in previous population-based studies.45–48 
Widespread body pain is a key feature of fibromyalgia, 
but the cross-sectional nature of this study does not allow 
investigation of temporal trends.47 A further indication 
of higher pain levels in ex-footballers is the significantly 
higher use of analgesics (41%) compared with controls 
(33%) and, in particular, NSAIDs (8.58% vs 4.20%) and 
OTC analgesics (24% vs 14%). The use of analgesics 
presumably reflects compromised musculoskeletal health, 
whereas in terms of systemic general health, the footbal-
lers reported significantly less diabetes, cancer, heart 
attacks and hypertension compared with controls. These 
results accord with previous studies of elite male athletes 
and ex-footballers with lower risk of ischaemic heart 
disease and diabetes, but an elevated risk of musculoskel-
etal conditions, particularly lower limb osteoarthritis.13 49 
Interestingly, ex-footballers reported significantly lower 
use of drugs such as citalopram, diazepam and temaz-
epam, which are used primarily in the treatment of 
depression and anxiety, respectively. Although the study 
was not powered for medication outcomes, the use of 
medication in the footballer cohort was primarily for pain 
relief rather than for relief for mental health problems. 
In fact, ex-footballers may have developed a certain resil-
ience and mental toughness due to being elite athletes, 
which may be a protective factor for long-term mental 
ill-health.4 37 49 50
There are several caveats to this study. First, this was a 
postal questionnaire study focused on pain and osteoar-
thritis in ex-footballers13 and a community sample,32 and 
so may be subject to response bias (those with pain are 
more likely to respond). However, this would not explain 
the between group differences. Second, the response rate 
was higher in the ex-footballer cohort than the controls 
(63.7% vs 22.6%), and the low response rate in controls 
questions the representativeness of the sample. Third, the 
comorbidities and medications were self-reported, and 
due to logistical reasons relating to questionnaire length, 
data on established associated risk factors for depression 
and anxiety, such as smoking status, alcohol consump-
tion, educational, marital and economic status,51–54 
were not available. Also, although the study did not find 
any differences between ex-footballers and controls in 
terms of mental health, it would have been interesting 
to examine mental toughness, resilience, optimism and 
general pain coping mechanisms between the two popu-
lations. Future epidemiological research on this topic 
should explore these relationships in more detail. Also, 
our use of the self-completed HADS alone is a limitation 
as this measure included only the symptoms of depression 
or anxiety as opposed to producing a definitive clinical 
diagnosis. Although we used the upper suggested cut-off 
of the HADS as a surrogate for probable depression and 
anxiety, the prevalence data for this dichotomous cut-off 
should be interpreted with this important caveat in mind. 
Furthermore, this study did not specifically measure two 
aspects of QoL: physical health via current physical activity 
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levels and social relations via personal relationships or 
available social support. These data would have given us 
insight into current physical fitness levels, physical limita-
tions as a consequence of musculoskeletal conditions and 
whether there was adequate psychosocial support in an 
individual’s life. These form some of the core tenets of a 
healthy QoL53 and may have offered robust data on previ-
ously reported anecdotal effects of bankruptcy, divorce or 
trauma, particularly in the ex-footballers.55 Finally, we did 
not examine the effects of repetitive heading of footballs 
and risk of head injury and concussion in professional 
footballers, and the possible long-term health impact that 
this could have on neurocognition and mental health. A 
future study is planned to address this issue.
In summary, this is the largest study on symptoms of 
anxiety and depression and QoL in ex-professional foot-
ballers and the first to include an age-adjusted general 
population comparison sample. The results show that 
ex-footballers are just as likely to have anxiety and depres-
sion symptoms as controls, but they have lower QoL in 
terms of both physical and mental composite scores. 
However, despite reporting more widespread body pain 
and use of analgesics, they are less likely to report cardio-
vascular disease or diabetes. The results suggest that 
healthcare providers, club management and football 
organisations should be focused on improving muscu-
loskeletal pain management strategies in ex-footballers. 
Further study on the potential benefits of professional 
sport on pain coping and resilience mechanisms, which 
may be protective factors for long-term psychological 
consequences such as depression and anxiety would 
benefit the large numbers of ex-professional footballers 
both nationally and internationally. It would also be valu-
able to explore the effects of neurocognitive functioning 
on mental health in ex-footballers and to capture the 
granularity around type, severity and frequencies of inju-
ries such as concussion and the subsequent long-term 
health impact.
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